Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Determination of Drug Levels to Optimize Pharmacotherapy of Heart Failure

NCT06035978 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.

NCT NCT06035978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06035978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Determination of Drug Levels to Optimize Pharmacotherapy of Heart Failure
Lead sponsor
University Hospital Ostrava
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2024
Completion date
April 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, heart failure with reduced ejection fraction